Pulmonary Fibrosis News and Research

RSS
Geron 2010 third quarter revenue increases from $494,000 to $546,000

Geron 2010 third quarter revenue increases from $494,000 to $546,000

Amira initiates AM152 Phase 1 clinical study for fibrotic diseases

Amira initiates AM152 Phase 1 clinical study for fibrotic diseases

Celgene third quarter non-GAAP total revenue increases 31% to $908 million

Celgene third quarter non-GAAP total revenue increases 31% to $908 million

PFF’s national scientific conference improves clinical understanding of IPF

PFF’s national scientific conference improves clinical understanding of IPF

CPF honors three critical areas of leadership for Pulmonary Fibrosis community

CPF honors three critical areas of leadership for Pulmonary Fibrosis community

Volunteers, families in IL, IN, NY, and PA unite to raise money and awareness about pulmonary fibrosis

Volunteers, families in IL, IN, NY, and PA unite to raise money and awareness about pulmonary fibrosis

Amira submits IND application for AM152 antagonist

Amira submits IND application for AM152 antagonist

New federal funds to create first national patient registry for pulmonary fibrosis

New federal funds to create first national patient registry for pulmonary fibrosis

InterMune's development program for pirfenidone, IPF to be presented at Annual Congress of ERS

InterMune's development program for pirfenidone, IPF to be presented at Annual Congress of ERS

Translational Research issue focuses field of stem cell research, therapy

Translational Research issue focuses field of stem cell research, therapy

Promedior initiates PRM-151 Phase 2a clinical study in prevention of scarring post glaucoma filtration surgery

Promedior initiates PRM-151 Phase 2a clinical study in prevention of scarring post glaucoma filtration surgery

Fundraising events in September in support of pulmonary fibrosis research

Fundraising events in September in support of pulmonary fibrosis research

Stromedix's STX-100 receives orphan drug status from FDA for treatment of IPF

Stromedix's STX-100 receives orphan drug status from FDA for treatment of IPF

PFF announces $400,000 grant for pulmonary fibrosis research

PFF announces $400,000 grant for pulmonary fibrosis research

NIH awards University of Rochester Medical Center $15M grant for study with ImmuneRegen's Homspera

NIH awards University of Rochester Medical Center $15M grant for study with ImmuneRegen's Homspera

CPF continues partnership with American Thoracic Society to fund Pulmonary Fibrosis research

CPF continues partnership with American Thoracic Society to fund Pulmonary Fibrosis research

Pulmonary Fibrosis Foundation to support 2010 National PF Week

Pulmonary Fibrosis Foundation to support 2010 National PF Week

Humanetics Corporation secures license to provide treatment for ionizing radiation exposure

Humanetics Corporation secures license to provide treatment for ionizing radiation exposure

CPF urges people to consider clinical trials for pulmonary fibrosis

CPF urges people to consider clinical trials for pulmonary fibrosis

PFF announces introduction of Pulmonary Fibrosis Research Enhancement Act in US Senate

PFF announces introduction of Pulmonary Fibrosis Research Enhancement Act in US Senate

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.